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Retroperitonel fibrosis is a rare disease that occasionally faces the general surgeon as a 
case of retroperitoneal tumour. Ureteric stenting may succeed in relieving urinary
obstruction, however, these stents are only for temporal use. For this reason and to 
exclude presence of retroperitoneal tumours, surgical ureterolysis remains the corner
stone for saving the kidneys from the ultimate fate of renal failure. Steroids are of help
when added to the surgical therapy. Recently tamoxifen was reported to be the treatment
of choice in primary retroperitoneal fibrosis.  
Here, we describe the management of 2 cases of idiopathic retroperitoneal fibrosis one 
in a police officer with diabetes mellitus and the other in a housewife.
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Case 1
A 48-years-old police officer presented 
to our surgical gastroenterology department, at the 
National Centre of Gastrointestinal and Liver
Diseases, with low back ache, persistent bilateral 
loin pain dull aching in nature, general ill -health, 
fatigue and loss of weight for six months. This
illness disabled him from conducting his work.  
On physical examination he was ill 
looking, not pale, jaundiced or cyanosed. Pulse 
88/min, respiratory rate 20/min, afebrile, BP
100/70. Cirvical lymph nodes were not palpable. 
His chest and cardiovascular systems were 
clinically normal. Examination of his abdomen 
revealed vague discomfort in both hypochondria 
and at the hypogastrium. There was mild 
tenderness at the renal angles on gentle fist 
percussion, but his kidneys were not palpable and
no other palpable abdominal masses. His femoral 
pulses were palpable, but rather feeble. Testis and 
scrotum were normal. Neither lower limb oedema 
nor varicose veins of lower limbs was detected.
Laboratory data 
His Hb was 10.6 gm/dl; WBC 5.3 × 109
/L, ESR 112 in first hour. Fasting blood sugar
160/dl, blood urea 95mg/dl, serum creatinine 3.2 
mg/dl, sodium 132 mmol/l, potassium 4.2 mmol/l. 
Glucose tolerance test showed a diabetic curve. 
Chest X-ray and ECG were normal. 
Ultrasonic scan revealed bilateral hydronephrosis
and a surapubic mass extending from the pelvis to
the pancreas and seems to encase the aorta. CT
scan documented a solid mass in the posterior
abdominal wall anterior and at both sides of the 
bodies of the lumber vertebrae extending from the 
pancreas down to the pelvis surrounding the aorta  
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and the inferior vena cava and their common iliac
branches with bilateral hydronephrosis (Fig 1 and
2). There were no para-aortic lymph nodes or liver
metastases. IVU was not done because of the high
blood urea. Retroperitoneal fibrosis, fibrosarcoma 
and lymphoma were considered as differential 
diagnoses.  
Hospital course 
The patient was put on insulin and an 
informed consent was taken for surgery. During
laparotomy dense fibrous tissue was found, in the 
retroperitoneal area, surrounding the aorta,
inferior vena cava, their iliac branches and both
ureters. Debulking of the vascular, tough fibrous
tissue mass was done and the excised tissue was
taken for histopathology. Ureters were freed from
below the pelvic brim up to the pelvis of the 
kidney.
The walls of the ureters were noted to be very
thick being infiltrated by the fibrous tissue. 
Ureters were then brought into the peritoneal 
cavity and covered with greater omentum. 
Common iliac vessels were freed partially from
the fibrous tissue. 




 Fig 2: Regression of the mass. 
Follow up 
The post operative period was 
uneventful. Histopathology reported benign 
fibrous tissue, no malignant change was seen. The 
appearance is consistent with retroperitoneal 
fibrosis.  
  Because of his diabetes and the incomplete
removal of the fibrous tissue mass the patient was 
put on prednisolone 60mg daily in divided doses 
tapered off after 2 months. He was followed up 
with serial ultrasonic scanning, renal function
tests and fasting blood sugar levels. Four months 
after completion of his first course CT scan was 
ordered. This showed that hydronephrosis has 
disappeared, and the size of the mass regressed 
(Fig 3 and 4) 
 His blood urea and serum creatinine returned 
back to normal. He was put on another similar 
course of prednisolone for a couple of months. He
is now followed up for 48 months and is in good 
condition with normal renal functions and 
controlled diabetes with 5mg Glibenclamide 
(Doanil, Wrexham-UK) daily.
Case 2
A 55–year-old lady presented with 
generalized aches and pains, fatigue and vague 
abdominal pain. On physical examination she was 
ill-looking, not pale, with normal vital signs and
bilateral loin tenderness.
Investigations revealed Hb 10 gm/dl WBC
5.600X9/ml ESR 120mmfirst hour. Ultrasound 
reported retroperitoneal mass with bilateral
hydronephrosis. CT scan with contrast showed
retroperitoneal mass with bilateral hydronephrosis 
but the right kidney is not functioning (Fig 3).  
Management:
She was put on combination of prednisolone 15 
mg tid for three months and Tamoxifen 10 mg bid 
for 6 months. 
Fig3: Bilateral hydonephrosis and right
nonfunctioning right kidney. 
Followup 
She showed progressive improvement. However,
she complained of feeling of vage generalized 
swelling. Follow up CT scan showed dramatic
regression of the retroperitoneal mass and 
complete resolution of the hydronephrosis but the 
right kidney became smaller in size (Fig 4). 
Fig 4 Regression of the retroperitoneal mass. 
Discussion
Retroperitoneal fibrosis was first described 
by Ormond in 19481 but two earlier cases were 
reported in the French literature one by Albarran 
in 1905 and the other by Kolischer in 1922 as 
suggested by Ormond himself2. The definitive 
cause of the idiopathic retroperitoneal fibrosis is 
not known. However, lar g e bowel strictures3,
mediastinal fibrosis4, orbital pseudo tumours5,
uveitis6 and sclerosing cholangitis7 were reported 
with idiopathic retroperitoneal fibrosis. None of 
these conditions are present in our cases however;
In the first case retroperitoneal fibrosis was 
associated with recent onset of diabetes mellitus. 
Although the retroperitoneal fibrosis in our case is 
extending up to the pancreas, unfortunately we 
didn’t take a biopsy from the tail of pancreas. 
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Therefore we are not sure whether his diabetes is 
due to infiltration of the pancreas by fibrosis or 
this association is a mater of chance only.  Yet, 
factors known to play a definite roll in 
retroperitoneal fibrosis are drugs like 
methysergide8, infections extending from 
diveticular disease of the colon or other pelvic 
organs, extravasation of urine, or healing after 
surgical procedures or traumatic injuries at the 
retroperitoneal area. Also, none of these was 
present in the second case.  
             Retroperitoneal fibrosis affect male as 
twice as females9. Our patients are 42 and 55 
years of age, this is consistent with the reported 
age of this disease which predominantly occurs in 
the forties and fifties10. Our patients presented 
with almost typical clinical features reported11 as 
backache, loss of weight, anorexia and general 
illhealth which is most likely attributed to the 
slow impairment of the renal function.  
Retroperitoneal fibrosis has predilection to 
obstruct the lower third of the ureter12, but each of 
our two patients seems to have presented with 
extensive disease involving the whole length of 
both ureters.  
IVU shows the diagnostic radiological features of 
retroperitoneal fibrosis as hydronephrosis due to 
extrinsic compression of the ureters which appear 
to be medially deviated13. In our first case we 
didn’t request IVU because of the renal 
impairment. Yet, because of fear of malignancy 
biopsy is the corner stone for the correct 
diagnosis. However, magnetic resonant imaging 
(MRI) is reported to differentiate between benign 
fibrosis and fibrosis infiltrated with malignancy14. 
MRI was introduced in this country two years 
after establishing the diagnosis of the first case. 
Histological confirmation of the diagnosis could 
be done by tru-cut needle biopsy15, however since 
surgical ureterolysis is essential we feel open 
biopsies and freeing of ureters and major vessels 
is more convenient. 
          To relief the ureteric obstruction ureteric 
stenting has high failure rate16. Therefore, open 
surgical ureterolysis remains the most important 
part of the treatment. It has withstood the test of 
time; although recent reports have shown that 
unilateral laparoscopic retroperitoneal ureterolysis 
carries less morbidity17. We have been doing 
laparoscopic cholecystectomy for more than 10 
years, yet we feel that laparoscopic retroperitoneal 
dissection requires special training. Open surgical 
ureterolysis does not completely excise the 
retroperitoneal fibrous mass, but it does free the 
ureters. Therefore a problem of unilateral 
recurrence and obstruction of retroperitoneal 
vessels resulting in lower limb oedema remain a 
challenge. In addition some patients may present 
too ill to with stand open bilateral ureterolysis. 
For these reasons and for all patients with 
retroperitoneal peritoneal fibrosis the use of 
steroids gave good results18-20. The duration of 
steroids is suggested to be between six months to 
two years. Because steroids are known to elevate 
the blood sugar, and in our patient the disease is 
associated with resent on set of diabetes we opted 
to give prednisolone in pulses every two months. 
However, it is of needless importance to stress in 
the fact that steroids should mot be given before 
biopsies were taken because of fear of missing 
cancer. However, the second case showed good 
response to combination of prednisolone and 
tamoxifen but she developed symptoms of salt 
and water retention which is expected to improve 
after withdrawal of the drugs.    
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